Clinical Trials Browser

Interventional × GDC-0084 × 90 days × Clear all

NCT07391215 2026-02-05

5G-PEARL

Phase 1/2 Recruiting

Glioblastoma

NCT03765983 2026-01-22

GDC-0084 in Combination With Trastuzumab for Patients With HER2-Positive Breast Cancer Brain Metastases

Phase 2 Terminated

Breast Neoplasms